Novo Nordisk A/S (NONOF)
| Previous close | 126.80 |
| Open | 118.90 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 118.90 - 128.35 |
| 52-week range | 74.70 - 140.32 |
| Volume | |
| Avg. volume | 42,548 |
| Market cap | 554.713B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 46.25 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.86 (1.51%) |
| Ex-dividend date | 22 Mar 2024 |
| 1y target est | N/A |
- GlobeNewswire
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred. Referring to Company Announcement no 32/2024 dated 24 April 2024, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 26 April 2024. Number of
- GlobeNewswire
Novo Nordisk A/S – Reduction of the share capital
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by cancellation of part of the company’s portfolio of own B shares equal to a nominal value of DKK 4,500,000 divided into 45,000,000 B shares of DKK 0.10 each. Today, Novo Nordisk has registered the implementation of the reduction of the share capital with the Danish Business Authority and cancelled B shares a
- GlobeNewswire
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 22 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme i
